Clinical Trial Update: Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment

View source ↗

Summary

NCI-sponsored clinical trial update describes collecting human samples to study hairy cell leukemia and other leukemias, and to develop recombinant immunotoxins…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Cutaneous T-cell Lymphoma
• Hairy Cell Leukemia
• Non-hodgkin Lymphoma
• T-cell Leukemia Lymphoma

Drugs mentioned

• Recombinant immunotoxins

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Hairy Cell Leukemia (HCL), Chronic Lymphocytic Leukemia (CLL) | Status: RECRUITING